厄贝沙坦预处理对心肌缺血再灌注损伤的影响

Effect of irbesartan pretreatment on myocardial ischemia/reperfusion injury in rats

  • 摘要: 目的 探讨厄贝沙坦预处理对大鼠心肌缺血再灌注后的作用及其可能的机制。 方法 健康雄性SD大鼠38只随机分为3组:假手术组(A组)、缺血/再灌注组(B组)、厄贝沙坦预处理组(C组);建立大鼠心肌缺血/再灌注(I/R)模型;TTC染色观察并测定心肌梗死面积、心肌结构,比色法检测血清丙二醛(malondialdehyde,MDA)浓度,生化检测肌钙蛋白(troponin I,TNI)含量,ELISA法检测血清肿瘤坏死因子(TNF-α)和白细胞介素-6(IL-6)的浓度。 结果 与缺血/再灌注组相比,厄贝沙坦组能明显减少心肌梗死面积(P< 0.05),减轻炎细胞浸润,改善心肌细胞结构,并且能使血清丙二醛(MDA)肌钙蛋白(TNI)和炎性介质(IL-6、TNF-α)的浓度减少(P< 0.01)。 结论 厄贝沙坦具有抗大鼠心肌缺血再灌注损伤的作用,可能通过减少炎症因子的合成或释放有关。

     

    Abstract: Objective To study the effect of irbesartan pretreatment on myocardial ischemia/reperfusion(I/R) injury in rats and its possible mechanism. Methods Thirty-eight healthy male SD rats were randomly divided into sham group(group A), I/R injury group(group B), and irbesartan pretreatment group(group C). A rat myocardial I/R injury model was established.Myocardial tissue samples were stained with TTC to observe the myocardial infarction size and myocardial cell structure. Serum malondialdehyde(MDA) concentration was measured by colorimetry, TNI content in rats was assayed by biochemical test, and serum tumor necrosis factor(TNF-α) and interleukin-6(IL-6) concentrations were measured by ELISA. Results The myocardial infarction size was smaller, the inflammatory cell infiltration was milder, the myocardial cell structure was better, and the serum MDA TNI, IL-6 and TNF-α concentrations were lower in group C than in group B(P< 0.05, P< 0.01). Conclusion Irbesartan pretreatment protects myocardium against I/R injury possibly by reducing the synthesis or releasing of inflammation factors.

     

/

返回文章
返回